SPRY2 and melanoma: Through an integrative approach analyzing genomic and gene expression changes in relation to in vivo growth aggressiveness, Mathieu et al. [166] found that genomic loss of Spry1 and Spry2—along with altered expression of some other genes—was associated with a more aggressive melanoma phenotype.